Cite
APA Citation
Elliott, M., Favre-Guilmard, C., Liu, S. M., Maignel, J., Masuyer, G., Beard, M., Boone, C., Carré, D., Kalinichev, M., Lezmi, S., Mir, I., Nicoleau, C., Palan, S., Perier, C., Raban, E., Zhang, S., Dong, M., Stenmark, P., & Krupp, J. (n.d.). botulinum neurotoxin B engineered for increased receptor affinity has improved clinical potential. Toxicon, 156, S27–S28. http://access.bl.uk/ark:/81055/vdc_100076796806.0x000054